Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN.
Authors
Valassi, EFranz, H
Brue, T
Feelders, R
Netea-Maier, R
Tsagarakis, S
Webb, S
Yaneva, M
Reincke, M
Droste, M
Komerdus, I
Maiter, D
Kastelan, D
Chanson, P
Pfeifer, M
Strasburger, C
Toth, M
Chabre, O
Krsek, M
Montañana, C
Bolanowski, M
Santos, A
Trainer, Peter J
Wass, J
Tabarin, A
Affiliation
Endocrinology, Hospital de la Santa Creu i Sant Pau, Barcelona, SpainIssue Date
2018-02-12
Metadata
Show full item recordAbstract
Surgery is the definitive treatment of Cushing's syndrome (CS) but medications may also be used as a first-line therapy. Whether preoperative medical treatment (PMT) affects postoperative outcome remains controversial.Citation
Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN. 2018, Eur J EndocrinolJournal
European Journal of EndocrinologyDOI
10.1530/EJE-17-0997PubMed ID
29440375Type
ArticleLanguage
enISSN
1479-683Xae974a485f413a2113503eed53cd6c53
10.1530/EJE-17-0997
Scopus Count
Collections
Related articles
- Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.
- Authors: Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JAH, Trainer PJ, ERCUSYN Study Group.
- Issue date: 2017 May
- The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.
- Authors: Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM, ERCUSYN Study Group.
- Issue date: 2011 Sep
- Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
- Authors: Kamenický P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J
- Issue date: 2011 Sep
- A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
- Authors: Valassi E, Aulinas A, Glad CA, Johannsson G, Ragnarsson O, Webb SM
- Issue date: 2017 Nov
- A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
- Authors: Valassi E, Crespo I, Gich I, Rodríguez J, Webb SM
- Issue date: 2012 Nov